title: Is less more: does leukopenia predict remission in patients with inflammatory bowel disease receiving thiopurine treatment?
authors.affiliation: Gastroenterology Unit, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Universitario de La Princesa, Playa de Mojácar 29, Urb. Bonanza, 28669, Boadilla del Monte, Madrid, Spain, javier.p.gisbert@gmail.com.
authors.forename: Javier P
authors.initials: JP
authors.lastname: Gisbert
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000453:epidemiology*; D003093:Colitis, Ulcerative / Q000453:epidemiology*; D003424:Crohn Disease / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007970:Leukopenia / Q000453:epidemiology*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D001379:Azathioprine